ArticleDermatologic therapy2022

Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single-center retrospective study in a real-life setting.

Matteo Megna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.